X imelagatran: An oral direct thrombin inhibitor.
- Published in:
- Indian Journal of Pharmacology, 2005, v. 37, n. 2, p. 132, doi. 10.4103/0253-7613.15119
- By:
- Publication type:
- Article
Works matching DE "ANTITHROMBINS"
Results: 1051
1
2
The new oral anticoagulants.
- Published in:
- Patient Care (Print), 2003, v. 37, n. 11, p. 13
- By:
- Publication type:
- Article
3
Designing a multifunctional staphylokinase variant (SAK-2RGD-TTI) with appropriate thrombolytic activity in vitro.
- Published in:
- Biotechnology Letters, 2020, v. 42, n. 1, p. 103, doi. 10.1007/s10529-019-02748-5
- By:
- Publication type:
- Article
4
A fast and simple approach to the quantitative evaluation of fibrinogen coagulation.
- Published in:
- Biotechnology Letters, 2014, v. 36, n. 2, p. 337, doi. 10.1007/s10529-013-1365-5
- By:
- Publication type:
- Article
5
Determination of melagatran in rabbit plasma by high-performance liquid chromatography with automated column switching.
- Published in:
- Biomedical Chromatography, 2003, v. 17, n. 6, p. 373, doi. 10.1002/bmc.242
- By:
- Publication type:
- Article
6
Single-shot antithrombin in human pancreas–kidney transplantation: reduction of reperfusion pancreatitis and prevention of graft thrombosis.
- Published in:
- Transplant International, 2006, v. 19, n. 6, p. 458, doi. 10.1111/j.1432-2277.2006.00325.x
- By:
- Publication type:
- Article
7
Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients.
- Published in:
- Transplant International, 2005, v. 18, n. 9, p. 1036, doi. 10.1111/j.1432-2277.2005.00173.x
- By:
- Publication type:
- Article
8
Renal transplant recipients with coronary artery disease exhibit impairment in fibrinolysis and structural changes in carotid arteries.
- Published in:
- Transplant International, 2005, v. 18, n. 2, p. 256, doi. 10.1111/j.1432-2277.2004.00027.x
- By:
- Publication type:
- Article
9
Thrombin inhibitory peptides derived from Mytilus edulis proteins: identification, molecular docking and in silico prediction of toxicity.
- Published in:
- European Food Research & Technology, 2018, v. 244, n. 2, p. 207, doi. 10.1007/s00217-017-2946-7
- By:
- Publication type:
- Article
10
A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain.
- Published in:
- Amino Acids, 2010, v. 38, n. 3, p. 691, doi. 10.1007/s00726-009-0267-2
- By:
- Publication type:
- Article
11
Thrombin Inhibitor, Argatroban, Prevents Tumor Cell Migration and Bone Metastasis.
- Published in:
- Oncology, 2004, v. 67, n. 2, p. 166, doi. 10.1159/000081004
- By:
- Publication type:
- Article
12
Effect of Xylan Sulfates on Coagulation of Human Blood Plasma.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2017, v. 164, n. 2, p. 158, doi. 10.1007/s10517-017-3947-z
- By:
- Publication type:
- Article
13
Antithrombin Activity of Erythrocyte Microvesicles.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2017, v. 162, n. 6, p. 718, doi. 10.1007/s10517-017-3696-z
- By:
- Publication type:
- Article
14
Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2017, v. 162, n. 4, p. 462, doi. 10.1007/s10517-017-3640-2
- By:
- Publication type:
- Article
15
Investigation of an anti-activated factor X (anti- Xa) assay for the quantification of enoxaparin in human plasma.
- Published in:
- Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 2, p. 209, doi. 10.1111/jphp.12333
- By:
- Publication type:
- Article
16
Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide.
- Published in:
- Communications Chemistry, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42004-021-00452-y
- By:
- Publication type:
- Article
17
Inhibition of in-stent restenosis after graphene oxide double-layer drug coating with good biocompatibility.
- Published in:
- Regenerative Biomaterials, 2019, v. 6, n. 5, p. 299, doi. 10.1093/rb/rbz010
- By:
- Publication type:
- Article
18
Bleeding Milky Way!
- Published in:
- Case Reports in Clinical Practice, 2021, v. 6, n. 4, p. 160
- By:
- Publication type:
- Article
19
Four new long-chain aliphatics from the feces of Trogopterus xanthipes.
- Published in:
- Journal of Asian Natural Products Research, 2009, v. 11, n. 12, p. 1032, doi. 10.1080/10286020903352518
- By:
- Publication type:
- Article
20
Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice.
- Published in:
- Pharmacy, 2023, v. 11, n. 1, p. 34, doi. 10.3390/pharmacy11010034
- By:
- Publication type:
- Article
21
Successful treatment for disseminated intravascular coagulation (DIC) corresponding to phenotype changes in a heat stroke patient.
- Published in:
- Journal of Intensive Care, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40560-019-0359-3
- By:
- Publication type:
- Article
22
An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome.
- Published in:
- Journal of Intensive Care, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40560-018-0339-z
- By:
- Publication type:
- Article
23
Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation.
- Published in:
- Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/5158308
- By:
- Publication type:
- Article
24
Antithrombin deficiency is associated with prothrombotic plasma fibrin clot phenotype.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 107
- By:
- Publication type:
- Article
25
Xenotransplantation literature update, July- August 2014.
- Published in:
- Xenotransplantation, 2014, v. 21, n. 5, p. 482, doi. 10.1111/xen.12144
- By:
- Publication type:
- Article
26
Recombinant human antithrombin prevents xenogenic activation of hemostasis in a model of pig-to-human kidney transplantation.
- Published in:
- Xenotransplantation, 2014, v. 21, n. 4, p. 367, doi. 10.1111/xen.12104
- By:
- Publication type:
- Article
27
RE-ALIGN: First trial of novel oral anticoagulant in patients with mechanical heart valves - The search continues.
- Published in:
- Global Cardiology Science & Practice, 2014, v. 2014, n. 1, p. 1, doi. 10.5339/gcsp.2014.13
- By:
- Publication type:
- Article
28
New perspectives and strategies in the treatment of thromboembolic diseases.
- Published in:
- Cardiologia Croatica, 2013, v. 8, n. 1/2, p. 11, doi. 10.15836/ccar.2013.11
- By:
- Publication type:
- Article
29
Pelvic arterial pseudoaneurysm — a rare complication of Cesarean section: diagnosis and novel treatment.
- Published in:
- 2007
- By:
- Publication type:
- Case Study
30
Differential Effects of Physiological Arousal Following Acute Stress on Police Officer Performance in a Simulated Critical Incident.
- Published in:
- Frontiers in Psychology, 2019, p. N.PAG, doi. 10.3389/fpsyg.2019.00759
- By:
- Publication type:
- Article
31
Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review.
- Published in:
- Journal of Intensive Care Medicine, 2017, v. 32, n. 5, p. 312, doi. 10.1177/0885066616656333
- By:
- Publication type:
- Article
32
Disseminated Intravascular Coagulopathy (DIC): Pathophysiology, Laboratory Diagnosis, and Management.
- Published in:
- Journal of Intensive Care Medicine, 2000, v. 15, n. 3, p. 144, doi. 10.1177/088506660001500303
- By:
- Publication type:
- Article
33
Genotype phenotype correlation in a pediatric population with antithrombin deficiency.
- Published in:
- 2019
- By:
- Publication type:
- journal article
34
Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation.
- Published in:
- European Journal of Pediatrics, 2014, v. 173, n. 3, p. 303, doi. 10.1007/s00431-013-2155-8
- By:
- Publication type:
- Article
35
Synthesis and biological evaluation of novel dabigatran derivatives as thrombin inhibitors.
- Published in:
- Research on Chemical Intermediates, 2016, v. 42, n. 2, p. 735, doi. 10.1007/s11164-015-2053-y
- By:
- Publication type:
- Article
36
Shape morphing of hydrogels by harnessing enzyme enabled mechanoresponse.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44607-y
- By:
- Publication type:
- Article
37
Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation: Answers to Challenging "Real-World" Questions.
- Published in:
- Thrombosis, 2012, p. 1, doi. 10.1155/2012/867121
- By:
- Publication type:
- Article
38
Reversible Crystallization of Argatroban after Subcutaneous Application in Pigs.
- Published in:
- Thrombosis, 2012, p. 1, doi. 10.1155/2012/560513
- By:
- Publication type:
- Article
39
Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban.
- Published in:
- Thrombosis, 2012, p. 1, doi. 10.1155/2012/108983
- By:
- Publication type:
- Article
40
Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden.
- Published in:
- Clinical Epidemiology, 2020, v. 12, p. 1029, doi. 10.2147/CLEP.S258373
- By:
- Publication type:
- Article
41
Deficiencies of Proteins C, S and Antithrombin and Activated Protein C Resistance - Their Involvement in the Occurrence of Arterial Thromboses.
- Published in:
- Journal of Medicine & Life, 2010, v. 3, n. 4, p. 412
- By:
- Publication type:
- Article
42
Deficiencies of proteins C, S and Antithrombin and factor V Leiden and the risk of ischemic strokes.
- Published in:
- Journal of Medicine & Life, 2010, v. 3, n. 3, p. 235
- By:
- Publication type:
- Article
43
Adverse Drug Reactions.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 299, n. 15, p. 1764, doi. 10.1001/jama.299.15.1764-c
- Publication type:
- Article
44
Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 21, p. 2497, doi. 10.1001/jama.298.21.2497
- By:
- Publication type:
- Article
45
Agents to Control Bleeding Show Promise.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 4, p. 349, doi. 10.1001/jama.297.4.349
- By:
- Publication type:
- Article
46
Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary Syndromes.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 294, n. 24, p. 3108, doi. 10.1001/jama.294.24.3108
- By:
- Publication type:
- Article
47
Ximelagatran—Promises and Concerns.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
48
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 6, p. 690, doi. 10.1001/jama.293.6.690
- Publication type:
- Article
49
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis: A Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 6, p. 681, doi. 10.1001/jama.293.6.681
- By:
- Publication type:
- Article
50
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 7, p. 853, doi. 10.1001/jama.289.7.853
- By:
- Publication type:
- Article